Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

  • Clinical Trials

    a clinician with a clinical trials patient

    Clinical trials are scientific studies in which new treatments – drugs, diagnostic procedures, and other therapies – are tested in patients to determine if they are safe and effective.

    Such trials help scientists answer questions about new cancer therapies, including: what diseases should they be used for? What doses of new drugs are most effective? And which patients can benefit the most from them?

    Nearly all cancer drugs in use today were tested and made available to patients through clinical trials.

    Search Dana-Farber clinical trials

    Search current cancer-related clinical trials offered through Dana-Farber and other Dana-Farber/Harvard Cancer Center member institutions.

    Search national clinical trials

    Search a registry of federally and privately supported clinical trials conducted in the United States and around the world.

    Should I participate in a clinical trial?

    If you’ve never been part of a clinical trial before, you may have concerns and questions about what to expect.

    In this video, patients and clinicians explain what clinical trials are and offer suggestions to help patients decide whether or not to enroll in a study.

    This video is not intended to be a substitute for discussion between you and your physician. If you are considering enrollment in a clinical trial, please talk to your clinical trial study team before making your decision.

    Frequently asked questions about clinical trials

    Who can participate in a clinical trial for cancer?

    To qualify for a particular study, participants must meet a carefully defined set of criteria. These usually relate to age and gender, cancer type and stage, and the types of treatments they have already received.

    What information do participants receive about clinical trials?

    Before agreeing to participate, patients learn about possible risks and benefits of the therapy being studied. As the trial progresses, participants are given new information that may affect their willingness to stay in the trial. Participants may withdraw from the trial at any time.

    How are patients protected?

    Before any clinical trial begins, it must be approved by its host institution's Institutional Review Board (IRB), which includes researchers and physicians. The IRB considers whether proposed studies are safe and well planned and whether they will ultimately advance patient care. It also reviews studies to ensure patients are adequately informed about the risks of participating in clinical research. In all studies, the health of each patient is closely monitored during the course of the trial.

    What are the different phases of a clinical trial for cancer?

    Cancer clinical trials are divided into three distinct stages. Only when the third stage has been successfully completed, and the Food and Drug Administration has given its approval, can a new treatment become part of standard therapy.

    Phase I trials

    Phase I trials are designed to determine the safety of a new cancer therapy. They evaluate how a new medication should be given (orally, intravenously, or by injection), how often, and at what dosage, but are not designed to test if a new therapy is effective. Phase I trials generally enroll only a small number of patients.

    Learn about Phase I clinical trials at Dana-Farber's Early Drug Development Center (EDDC)

    Phase II trials

    Phase II trials provide information about how well a new medication works and generate more information about patient safety. Phase II studies usually focus on a specific type of cancer.

    Phase III trials

    Phase III trials compare new treatments with standard ones to determine which is safer and more effective. Phase III trials generally involve a large number of participants and often take place at several health centers at the same time. Patients are randomly assigned to receive either the new cancer therapy or a standard one.

    Read our Insight blog for information and inspiration about Dana-Farber's clinical trials.

  •   Email
  •   Print
  •   Share
  • Find a Researcher

    Search by last name:

  • Personalized Medicine Study

    • Barrett Rollins, MD, PhD and Neil Lindeman, MD Learn about Profile, one of the most comprehensive cancer research studies to focus on the development of targeted treatments for every person with cancer.
  • Five new FDA drug approvals from Dana-Farber-led clinical trials

    • Bruce Johnson, MDIn a five-week span, the U.S. Food and Drug Administration (FDA) approved five new cancer drugs that proved effective in Dana-Farber-led clinical trials – some from basic research in Dana-Farber labs.
  • Clinical trial "recharges" brain tumor survivor

    • Kevin BradleyDespite surgery, Kevin Bradley’s glioblastoma returned. But a clinical trial drug has enabled him to remain stable since 2007.
  • Clinical Trial Summaries

    • Dana-Farber's Breast Oncology Center is launching an effort to provide summaries of the results of its clinical trials.
    • View a summary of the recently published APT clinical trial results.
  • Support Cancer Research

    • To learn more about the many ways you can support Dana-Farber’s research initiatives with a philanthropic gift, please contact Rebecca Freedman at 617-632-4215 or rebecca_freedman@
    • Give Now